Dobutamine NDC 70436-203

NDC codes

FDA NDC Directory

Product NDC (as listed)70436-203Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70436-0203Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70436-203-80	70436020380	1 VIAL, SINGLE-DOSE in 1 CARTON (70436-203-80) / 20 mL in 1 VIAL, SINGLE-DOSEMarketed from Apr 3, 2023
70436-203-82	70436020382	10 VIAL, SINGLE-DOSE in 1 CARTON (70436-203-82) / 20 mL in 1 VIAL, SINGLE-DOSEMarketed from Apr 3, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dobutamine
Generic name (nonproprietary): dobutamine
Active ingredients: Dobutamine hydrochloride — 250 mg/20mL
Dosage form: Injection
Route: Intravenous
Labeler: Slate Run Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216131
Marketing start: Apr 3, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Agonists (Mechanism)
Identifiers: Product ID 70436-203_49562559-8e19-fb8a-e063-6394a90a0966SPL ID 49562559-8e19-fb8a-e063-6394a90a0966SPL set ID ee09a55f-9992-48bb-b8d6-1184bd548536RxCUI 1812168UNII 0WR771DJXVUPC 0370436203802
Pharmacologic class: beta-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470436020380 followed by a unit qualifier and the quantity

Package 70436-0203-80. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 26, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Dobutamine Injection, USP is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures. Experience with intravenous dobutamine in controlled trials does not extend beyond 48 hours of repeated boluses and/or continuous infusions. Whether given orally, continuously intravenously, or intermittently intravenously, neither dobutamine nor any other cyclic-AMP-dependent inotrope has been shown in controlled trials to be safe or effective in the long-term treatment of congestive heart failur…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)